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Abstract
    Lymphomatoid granulomatosis (LG) is an angiocentric lymphoproliferative disease. It usually involves lung, skin, and central nervous 
system, but splenomegaly and pancytopenia are the rare manifestations of the disease. We report a 15-year-old boy presented with fever, 
dry cough and dyspnea from two months ago, after admission patient had nodular lesions on the left leg and hepatosplenomegaly. Then 
he manifested neurologic signs such as seizure, aphasia and right-sided hemiplegia. Chest X-ray and CT scan revealed bilateral pulmonary 
nodules predominantly in lower lobes and peripheral lung fields. Laboratory exams showed pancytopenia. Skin biopsy was done, and 
histopathological examination and immunohistochemistry evaluation confirmed lymphomatoid granulomatosis. He was treated with 
steroid and cyclophosphamide but succumbed by neurologic involvement.  
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Introduction 
    Liebow et al
[1] first described lymphomatoid granulomatosis 
(LG) as a triad of polymorphic lymphoid infiltrate, angiitis, 
and granulomatosis in 1972. It is a rare Epstein-bar virus as-
sociated with systemic angiodestructive lymphoproliferative 
disease, currently it is described as an Epstein-Barr-virus-
positive and T-cell-rich B-cell lymphoproliferative disorder
[2]. 
Eventhough LG mimics Wegener’s granulomatosis and fre-
quently discussed in the context of the vasculitides, it is a lym-
phoproliferative disorder, not primary vasculitis
[3]. The disease 
generally occurs in patients in their 40s and has a strong male 
predominance
[4,5]. 
Patients often presents with fever, malaise, cough and dys-
pnea, the presenting symptom and signs are suggestive of in-
fectious disease
[6]. 
We present a 15-year-old man who was admitted because of 
cough, dyspnea, hepatosplenomegaly, pancytopenia, nodular 
and alveolar lung lesions and demonstrated many difficulties in 
diagnosis of lymphomatoid granulomatosis.
Case description 
A 15-year-old boy was admitted with a 2-month history of 
fever, decreased appetite and nonproductive cough. Cough 
and fever progressed despite of antibiotics prescription for pre-
sumed community-acquired pneumonia a few weeks prior to 
admission. 
At the time of admission, he had fever, tachycardia, respira-
tory distress and splenomegaly. In laboratory findings, he had 
pancytopenia; urine analysis and ESR was normal, blood and 
urine culture was negative. Gram stain of his sputum showed 
gram positive cocci. Acid fast bacillus was not found in sputum 
smear. HBsAg and Anti-HCV and Anti-HIV were negative. 
ANA, Anti ds-DNA, p-ANCA and c-ANCA were requested 
but all of them were negative. Peripheral blood smear and bone 
marrow aspiration were normal. Echocardiography also was 
normal. His chest X-ray and CT-scan of thorax showed bilater-
al and peripheral nodular and alveolar pattern, predominantly 
in lower lobes of the lung. Mediastinal lymphadenopathy and 
pleural effusion were not seen (Fig 1). Abdominal sonography 
and CT showed hepatosplenomegaly. Splenomegaly was more 
prominent than hepatomegaly. Para-aortic lymphadenopathy 
was not seen. Bronchoscopy and open lung biopsy were not 
performed because the patient’s guardian did not permit. Two 
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leg (Fig 2). Skin excisional biopsy was taken. One day later, 
he developed right hemiplegia, seizure and aphasia. Brain CT 
scan showed a broad hypo dense area on the left temporal and 
basal ganglia that had little enhancement after injection of IV 
contrast (Fig 3). At this time, the result of skin biopsy was 
prepared. There was severe infiltration of lymphocytes and 
histiocytes and atypical lymphocytes on the subcutaneous and 
deep parts of the derma. The main aggregation of the cells was 
around the vessels and nerves and appendices of the skin. The 
endothelial layer of the vessels had inflammation, but there was 
no morphologic pattern of vasculitis. Lymphoid cells had posi-
tive reaction with CD45RO: so lymphomatoid granulomatosis 
(LG) was diagnosed (Fig 4). He was treated with steroid pulse 
therapy and oral cyclophosphamide but after 12 days he ex-
pired without any clinical improvement and any response to 
the treatment. 
Discussion
Lymphomatoid granulomatosis can affect any organ but it 
is found most frequently in the lung, central nervous system 
and skin. Pulmonary involvement is almost invariably a feature 
of LG. The radiological appearance of LG is multiple bilateral 
pulmonary nodules involving the lower and peripheral lung 
fields. Cavitations, atelectasis or lobar obstruction, large mass-
like disease, and pneumothorax may be seen in LG. The pul-
monary lesions typically wax and wane and some areas may 
regress while others are progressing
[4,6]. Sometime, lymphoma-
toid granulomatosis shows CT features such as peribroncho-
vascular distribution of nodules and coarse irregular opacities, 
small thin-walled cysts, and small conglomerating nodules
[7]. 
The reported patient had nodular and alveolar lesions mostly 
in the peripheral and lower lobes. 
Skin is the second most commonly affected organ in LG 
that has been reported in up to 55% of cases. Skin can reveal 
rash, subcutaneous nodules, or ulceration. These lesions are 
generally painless, but can occasionally be tender and pruritic. 
They are usually small and nonconfluent and often on the 
extremities
[6]. The reported patient had painless nodular skin 
lesions on the left leg a few days after the onset of his illness.
The CNS is involved in 20% of LG patients but it is rare as 
an initial presentation
[8]. It is characterized by focal deficits in 
an asymmetric distribution, sometimes with seizures, ataxia, 
cranial nerve disorders, and peripheral neuropathy
[6,8]. The 
CT appearance of cerebral involvement is diverse. The disease 
which is most commonly seen as low-attenuation areas in the 
white matter is sometimes hemorrhagic and often enhances 
with IV contrast material
[9]. Neurologic manifestation is an ad-
verse prognostic factor. In our patient, the CT revealed nearly 
extensive hypo dense lesions at the left temporal area and basal 
Fig 1  Chest X-ray and CT-scan of thorax Fig 2  Few small brown nodular lesions on the left leg
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ganglia.
Renal and hepatic involvement is unusual. Hepatic involve-
ment may carry a worse prognosis. Lymph node and splenic 
involvement is rare and do not appear to adversely affect prog-
nosis
[6]. Our patient had prominent hepatosplenomegaly.
There are no characteristic laboratory values in LG
[6]. CBC 
is usually normal but sometimes reveals mild leucopenia or 
leukocytosis
[1]. This patient had pancytopenia that initially im-
proved by treatment.
The diagnosis of LG requires examination of affected tissue 
biopsy, usually lung, skin, or head and neck
[3]. The biopsies 
from lung, skin or CNS has the same value
[1]. There is a necro-
tizing, angiocentric, and angiodestructive infiltrative process. 
The key microscopic picture is the presence of poly-morphic 
infiltration of plasma cells, immunoblasts, and typical large 
lymphoid cells with a tendency to involve the wall of pulmonary 
vessels and to collect in the subendothelial spaces. The multinucle-
ated giant cells and necrotizing changes of Wegener’s granuloma-
tosis are not present. Prominent vascular involvement without 
necrotic changes is also seen in the cutaneous lesions of LG. 
The necrotic component is prominent and results in extensive 
parenchymal destruction. Real granulomatose inflammation, 
however, does not occur
[1,10]. Immunohistochemistry shows 
that most of the cells-small to medium-sized lymphocytes are 
T cells (CD45RO+); however, a much smaller population of 
medium-sized to large atypical cells are B cells (CD20+). In 
each case, these cells are combined. Most cases of LG involv-
ing in the lung represent a proliferation of Epstein-Barr virus 
infected B-cells with a prominent T-cell reaction and vasculitis, 
distinguishing these cases from angiocentric "T-cell lympho-
mas" in other sites (such as the head and neck)
[11]. We planed 
open lung biopsy as diagnostic procedure for this patient but 
because the patient’s guardian did not permit and the biopsies 
from lung and skin has the same value, we performed skin ex-
cisional biopsy. Histopathology and immunohistochemistry 
evaluation confirmed lymphomatoid granulomatosis.
The disease usually progresses relentlessly, eventuating in 
death. However, spontaneous remissions have been described. 
Its pathophysiology is unclear in numerous respects, thus 
making it difficult to diagnose and treat
[12]. In earlier studies 
responses are noted to regimen of oral cyclophosphamide and 
corticosteroid (prednisolone)
[2,13]. Responses to INF-alpha 
2b are reported anecdotally, but the experiences are limited to 
only few cases
[3,14]. There are reports of both clinical and patho-
logical remission by anti-CD20 monoclonal antibody (Ritux-
imab)
[15]. Clinicopathologic studies have shown that progres-
sion of LG to lymphoma occurs in 12%-47% of patients, and 
the mortality rate has been reported to be between 53% and 
63.5%
[7]. Adverse prognostic factors include neurologic mani-
festations, and large numbers of atypical lymphoreticular cells 
within the pulmonary infiltrate. Unilateral chest lesions and 
large numbers of small lymphocytes and histiocytes within the 
infiltrate are associated with a better prognosis
[13]. 
Prognosis is generally poor. The death usually occurs within 
14 months from the time of diagnosis. Half or more of patients 
succumb to the disease within five years
[5]. 
This patient was treated with steroid pulse therapy and oral 
cyclophosphamide but after 12 days he expired without any 
clinical benefit of the treatment.
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